Gold
Compare Stocks
4 / 10Stock Comparison
NEM vs LIN vs ALB vs ECL
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
Chemicals - Specialty
Chemicals - Specialty
NEM vs LIN vs ALB vs ECL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Gold | Chemicals - Specialty | Chemicals - Specialty | Chemicals - Specialty |
| Market Cap | $127.53B | $232.56B | $22.70B | $74.40B |
| Revenue (TTM) | $17.23B | $34.66B | $5.49B | $16.08B |
| Net Income (TTM) | $5.26B | $7.13B | $-275M | $2.08B |
| Gross Margin | 52.1% | 46.0% | 18.5% | 44.5% |
| Operating Margin | 49.3% | 28.8% | 5.6% | 17.7% |
| Forward P/E | 11.0x | 28.1x | 21.7x | 31.5x |
| Total Debt | $474M | $26.99B | $3.30B | $9.43B |
| Cash & Equiv. | $7.65B | $5.06B | $1.62B | $646M |
NEM vs LIN vs ALB vs ECL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Newmont Corporation (NEM) | 100 | 196.9 | +96.9% |
| Linde plc (LIN) | 100 | 248.0 | +148.0% |
| Albemarle Corporati… (ALB) | 100 | 251.7 | +151.7% |
| Ecolab Inc. (ECL) | 100 | 123.9 | +23.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NEM vs LIN vs ALB vs ECL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NEM carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth 19.1%, EPS growth 124.1%, 3Y rev CAGR 22.7%
- Lower volatility, beta 0.75, Low D/E 1.4%, current ratio 1.72x
- PEG 0.86 vs LIN's 1.11
- 19.1% revenue growth vs ALB's -4.4%
LIN is the #2 pick in this set and the best alternative if income & stability and long-term compounding is your priority.
- Dividend streak 6 yrs, beta 0.24, yield 1.2%
- 376.9% 10Y total return vs NEM's 271.4%
- Beta 0.24, yield 1.2%, current ratio 0.88x
- Beta 0.24 vs ALB's 1.60
ALB is the clearest fit if your priority is momentum.
- +237.9% vs ECL's +5.4%
ECL lags the leaders in this set but could rank higher in a more targeted comparison.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 19.1% revenue growth vs ALB's -4.4% | |
| Value | Lower P/E (11.0x vs 31.5x) | |
| Quality / Margins | 30.5% margin vs ALB's -5.0% | |
| Stability / Safety | Beta 0.24 vs ALB's 1.60 | |
| Dividends | 1.2% yield, 6-year raise streak, vs ALB's 0.8% | |
| Momentum (1Y) | +237.9% vs ECL's +5.4% | |
| Efficiency (ROA) | 9.4% ROA vs ALB's -1.7%, ROIC 24.9% vs 0.6% |
NEM vs LIN vs ALB vs ECL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
NEM vs LIN vs ALB vs ECL — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NEM leads in 3 of 6 categories
LIN leads 1 • ALB leads 0 • ECL leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NEM leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
LIN is the larger business by revenue, generating $34.7B annually — 6.3x ALB's $5.5B. NEM is the more profitable business, keeping 30.5% of every revenue dollar as net income compared to ALB's -5.0%. On growth, ALB holds the edge at +32.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $17.2B | $34.7B | $5.5B | $16.1B |
| EBITDAEarnings before interest/tax | $12.7B | $12.1B | $802M | $3.5B |
| Net IncomeAfter-tax profit | $5.3B | $7.1B | -$275M | $2.1B |
| Free Cash FlowCash after capex | $12.9B | $5.1B | $577M | $1.9B |
| Gross MarginGross profit ÷ Revenue | +52.1% | +46.0% | +18.5% | +44.5% |
| Operating MarginEBIT ÷ Revenue | +49.3% | +28.8% | +5.6% | +17.7% |
| Net MarginNet income ÷ Revenue | +30.5% | +20.6% | -5.0% | +12.9% |
| FCF MarginFCF ÷ Revenue | +75.0% | +14.7% | +10.5% | +11.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | -100.0% | +8.2% | +32.7% | +4.8% |
| EPS Growth (YoY)Latest quarter vs prior year | -100.0% | +13.4% | — | +19.3% |
Valuation Metrics
Evenly matched — NEM and ALB each lead in 3 of 7 comparable metrics.
Valuation Metrics
At 18.0x trailing earnings, NEM trades at a 50% valuation discount to ECL's 36.2x P/E. Adjusting for growth (PEG ratio), LIN offers better value at 1.36x vs NEM's 1.40x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $127.5B | $232.6B | $22.7B | $74.4B |
| Enterprise ValueMkt cap + debt − cash | $120.4B | $254.5B | $24.4B | $83.2B |
| Trailing P/EPrice ÷ TTM EPS | 17.96x | 34.40x | -33.50x | 36.18x |
| Forward P/EPrice ÷ next-FY EPS est. | 11.05x | 28.12x | 21.72x | 31.46x |
| PEG RatioP/E ÷ EPS growth rate | 1.40x | 1.36x | — | — |
| EV / EBITDAEnterprise value multiple | 9.17x | 20.04x | 32.31x | 23.20x |
| Price / SalesMarket cap ÷ Revenue | 5.77x | 6.84x | 4.41x | 4.63x |
| Price / BookPrice ÷ Book value/share | 3.75x | 5.92x | 2.32x | 7.66x |
| Price / FCFMarket cap ÷ FCF | 17.47x | 45.70x | 32.78x | 39.07x |
Profitability & Efficiency
NEM leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
ECL delivers a 22.0% return on equity — every $100 of shareholder capital generates $22 in annual profit, vs $-3 for ALB. NEM carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to ECL's 0.96x. On the Piotroski fundamental quality scale (0–9), NEM scores 9/9 vs ECL's 5/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +15.6% | +17.8% | -2.7% | +22.0% |
| ROA (TTM)Return on assets | +9.4% | +8.3% | -1.7% | +8.8% |
| ROICReturn on invested capital | +24.9% | +11.3% | +0.6% | +12.7% |
| ROCEReturn on capital employed | +20.7% | +13.0% | +0.6% | +15.8% |
| Piotroski ScoreFundamental quality 0–9 | 9 | 6 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.01x | 0.68x | 0.34x | 0.96x |
| Net DebtTotal debt minus cash | -$7.2B | $21.9B | $1.7B | $8.8B |
| Cash & Equiv.Liquid assets | $7.6B | $5.1B | $1.6B | $646M |
| Total DebtShort + long-term debt | $474M | $27.0B | $3.3B | $9.4B |
| Interest CoverageEBIT ÷ Interest expense | 50.54x | 34.52x | 0.57x | 9.82x |
Total Returns (Dividends Reinvested)
NEM leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NEM five years ago would be worth $18,360 today (with dividends reinvested), compared to $12,030 for ECL. Over the past 12 months, ALB leads with a +237.9% total return vs ECL's +5.4%. The 3-year compound annual growth rate (CAGR) favors NEM at 34.9% vs ALB's 2.0% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +14.0% | +17.3% | +34.1% | +0.6% |
| 1-Year ReturnPast 12 months | +112.6% | +13.6% | +237.9% | +5.4% |
| 3-Year ReturnCumulative with dividends | +145.5% | +41.9% | +6.2% | +56.7% |
| 5-Year ReturnCumulative with dividends | +83.6% | +78.1% | +31.2% | +20.3% |
| 10-Year ReturnCumulative with dividends | +271.4% | +376.9% | +202.4% | +142.1% |
| CAGR (3Y)Annualised 3-year return | +34.9% | +12.4% | +2.0% | +16.2% |
Risk & Volatility
LIN leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
LIN is the less volatile stock with a 0.24 beta — it tends to amplify market swings less than ALB's 1.60 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LIN currently trades 96.3% from its 52-week high vs ECL's 85.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.75x | 0.24x | 1.60x | 0.63x |
| 52-Week HighHighest price in past year | $134.88 | $521.28 | $215.69 | $309.27 |
| 52-Week LowLowest price in past year | $48.27 | $387.78 | $53.70 | $249.04 |
| % of 52W HighCurrent price vs 52-week peak | +85.3% | +96.3% | +89.3% | +85.2% |
| RSI (14)Momentum oscillator 0–100 | 46.1 | 50.6 | 54.6 | 38.4 |
| Avg Volume (50D)Average daily shares traded | 9.2M | 2.3M | 2.0M | 1.4M |
Analyst Outlook
Evenly matched — LIN and ALB each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: NEM as "Buy", LIN as "Buy", ALB as "Hold", ECL as "Buy". Consensus price targets imply 24.2% upside for ECL (target: $327) vs -0.9% for ALB (target: $191). For income investors, LIN offers the higher dividend yield at 1.20% vs ALB's 0.84%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $137.50 | $539.71 | $190.80 | $327.11 |
| # AnalystsCovering analysts | 36 | 28 | 45 | 37 |
| Dividend YieldAnnual dividend ÷ price | +0.9% | +1.2% | +0.8% | +1.0% |
| Dividend StreakConsecutive years of raises | 1 | 6 | 15 | 12 |
| Dividend / ShareAnnual DPS | $1.00 | $6.00 | $1.62 | $2.64 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.8% | +2.0% | 0.0% | +1.1% |
NEM leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). LIN leads in 1 (Risk & Volatility). 2 tied.
NEM vs LIN vs ALB vs ECL: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is NEM or LIN or ALB or ECL a better buy right now?
For growth investors, Newmont Corporation (NEM) is the stronger pick with 19.
1% revenue growth year-over-year, versus -4. 4% for Albemarle Corporation (ALB). Newmont Corporation (NEM) offers the better valuation at 18. 0x trailing P/E (11. 0x forward), making it the more compelling value choice. Analysts rate Newmont Corporation (NEM) a "Buy" — based on 36 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NEM or LIN or ALB or ECL?
On trailing P/E, Newmont Corporation (NEM) is the cheapest at 18.
0x versus Ecolab Inc. at 36. 2x. On forward P/E, Newmont Corporation is actually cheaper at 11. 0x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Newmont Corporation wins at 0. 86x versus Linde plc's 1. 11x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — NEM or LIN or ALB or ECL?
Over the past 5 years, Newmont Corporation (NEM) delivered a total return of +83.
6%, compared to +20. 3% for Ecolab Inc. (ECL). Over 10 years, the gap is even starker: LIN returned +376. 9% versus ECL's +142. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NEM or LIN or ALB or ECL?
By beta (market sensitivity over 5 years), Linde plc (LIN) is the lower-risk stock at 0.
24β versus Albemarle Corporation's 1. 60β — meaning ALB is approximately 565% more volatile than LIN relative to the S&P 500. On balance sheet safety, Newmont Corporation (NEM) carries a lower debt/equity ratio of 1% versus 96% for Ecolab Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — NEM or LIN or ALB or ECL?
By revenue growth (latest reported year), Newmont Corporation (NEM) is pulling ahead at 19.
1% versus -4. 4% for Albemarle Corporation (ALB). On earnings-per-share growth, the picture is similar: Newmont Corporation grew EPS 124. 1% year-over-year, compared to -1. 2% for Ecolab Inc.. Over a 3-year CAGR, NEM leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NEM or LIN or ALB or ECL?
Newmont Corporation (NEM) is the more profitable company, earning 32.
1% net margin versus -9. 9% for Albemarle Corporation — meaning it keeps 32. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NEM leads at 46. 9% versus 1. 8% for ALB. At the gross margin level — before operating expenses — NEM leads at 49. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NEM or LIN or ALB or ECL more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Newmont Corporation (NEM) is the more undervalued stock at a PEG of 0. 86x versus Linde plc's 1. 11x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Newmont Corporation (NEM) trades at 11. 0x forward P/E versus 31. 5x for Ecolab Inc. — 20. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ECL: 24. 2% to $327. 11.
08Which pays a better dividend — NEM or LIN or ALB or ECL?
All stocks in this comparison pay dividends.
Linde plc (LIN) offers the highest yield at 1. 2%, versus 0. 8% for Albemarle Corporation (ALB).
09Is NEM or LIN or ALB or ECL better for a retirement portfolio?
For long-horizon retirement investors, Linde plc (LIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
24), 1. 2% yield, +376. 9% 10Y return). Albemarle Corporation (ALB) carries a higher beta of 1. 60 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (LIN: +376. 9%, ALB: +202. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NEM and LIN and ALB and ECL?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: NEM is a mid-cap high-growth stock; LIN is a large-cap quality compounder stock; ALB is a mid-cap quality compounder stock; ECL is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.